Accessibility Menu
Cassava Sciences Stock Quote

Cassava Sciences (NASDAQ: SAVA)

$3.75
(-5.8%)
-0.23
Price as of October 22, 2025, 11:44 a.m. ET

KEY DATA POINTS

Current Price
$3.75
Daily Change
(-5.8%) $0.23
Day's Range
$3.7 - $4.02
Previous Close
$3.98
Open
$3.96
Beta
1.18
Volume
1,357,114
Average Volume
2,482,590
Market Cap
192.3M
Market Cap / Employee
$3.98M
52wk Range
$1.15 - $33.98
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$2.56
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Cassava Sciences Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SAVA-86.22%-54.93%-14.73%-96%
S&P+15.06%+95.03%+14.29%+346%

Cassava Sciences Company Info

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.20M33.3%
Market Cap$87.44M-85.2%
Market Cap / Employee$2.91M0.0%
Employees303.4%
Net Income-$44.22M-818.5%
EBITDA-$45.19M32.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$112.38M-45.8%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.00M0.0%
Short Term Debt$0.00M0.0%

Ratios

Q2 2025YOY Change
Return On Assets-65.00%-58.0%
Return On Invested Capital-28.11%0.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$4.95M72.9%
Operating Free Cash Flow-$4.95M72.9%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book8.470.680.500.69-89.92%
Price to Tangible Book Value8.480.680.500.69-89.93%
Enterprise Value to EBITDA-38.870.521.840.55-110.16%
Return on Equity-11.0%-17.2%-70.6%-88.9%965.62%
Total Debt$0.00M$0.00M$0.00M$0.00M-

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.